Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Great Basin Scientific, Inc. (GBSN)
|
Add to portfolio |
|
|
|
| Price: |
$0.11
| | Metrics |
| OS: |
1.98
|
M
| |
|
|
| Market cap: |
$217.6
|
k
| |
-174
|
% ROIC
|
|
Net debt:
|
$33.3
|
M
| |
|
|
|
EV:
|
$33.5
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($30.8)
|
M
| |
|
|
|
EBIT
|
($33.4)
|
M
| |
|
|
| EPS |
($108.48)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| Revenues | 3.0 | 2.1 | 1.6 | 0.8 |
| Revenue growth | 42.3% | 33.4% | 111.2% | |
| Cost of goods sold | 8.1 | 4.8 | 4.0 | 2.2 |
| Gross profit | -5.0 | -2.7 | -2.4 | -1.4 |
| Gross margin | -164.5% | -124.7% | -147.0% | -187.4% |
| Sales and marketing | 6.9 | 5.0 | 2.3 | 2.6 |
| Research and development | 13.4 | 8.5 | 4.6 | 3.3 |
| General and administrative | 8.8 | 6.2 | 2.9 | 1.9 |
| EBITA | -34.0 | -22.3 | -12.1 | -9.2 |
| EBITA margin | -1115.6% | -1041.5% | -751.8% | -1207.1% |
| Amortization of intangibles | 0.1 | 0.1 | 0.1 | 0.1 |
| EBIT | -34.1 | -22.4 | -12.2 | -9.3 |
| EBIT margin | -1118.1% | -1046.0% | -759.1% | -1220.0% |
| Pre-tax income | -89.1 | -57.9 | -21.7 | -9.6 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income | -89.1 | -57.9 | -21.7 | -12.1 |
| Net margin | -2924.7% | -2703.0% | -1352.7% | -1590.1% |
| |
| Diluted EPS | ($798.17) | ($121,636.91) | ($1,039.41) | ($104.71) |
| Shares outstanding (diluted) | 0.1 | 0.0 | 0.0 | 0.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|